CONGRESS GUIDE

Recommendations

Info

ERS International Congress 2016 DETAILED PROGRAMME TUESDAY 06 SEPTEMBER, 2016 PA4453 Cardiorespiratory physiotherapy as a career choice in Portugal Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Ana Machado, Ana Oliveira, Cristina Jácome, Joana Cruz, Tânia Pinho, Dina Brooks, Alda Sofia Pires de Dias Marques Room E Session 619 13:00 - 14:30 Lunchtime session: Early life origins of asthma and COPD ERS/NEJM Lunchtime session Aims : To present how microbial and environmental exposures in early life modify the risk of developing asthma and COPD. Target audience : Allied health professional, Clinician, General practitioner, Paediatrician, Pulmonologist, Scientist Chairs : Erika von Mutius (Munich, Germany), Soren Pedersen (Kolding, Denmark) 13:00 13:30 How microbial and environmental exposures in early life modify the risk of developing asthma and COPD Urs Frey (Basel, Switzerland) Links between childhood and adult airway obstruction Andrew Bush (LONDON, United Kingdom) 4454 4455 14:00 What are the common biological mechanisms that lead to obstructive airway disease? Fernando D. Martinez (Tucson, United States of America) Prince Regent Room Session 620 13:00 - 14:30 Lunchtime session: Should we start screening programmes in Europe? Review of current scientific evidence Aims : To present the latest data concerning our capacity to early diagnose cancers; discuss and explain apparently divergent results from different trials;) describe the possible harms that relate to the screening and diagnosis process; and detail the different approaches with imaging modalities. Track(s) : Oncology Chairs : Georgia Hardavella (London, United Kingdom), Sam Janes (London, United Kingdom) 4456 13:00 13:22 Two dimensional versus three dimensional analysis of nodules detected during screening Martine Remy-Jardin (Lille, France) How to deal with the detected nodule ? David Baldwin (Nottingham, United Kingdom) 4457 4458 13:44 CT screening: the evidence 4459 14:06 What are the current recommendations for screening and which one should we implement? 4460 Room L Session 621 13:00 - 14:30 Lunchtime session: GOLD: novel approaches to COPD assessment and management Aims : To describe new developments regarding the definition and assessment of COPD, the evaluation and treatment of comorbidities, and the definition, treatment, and prevention of exacerbations. Tag(s) : Clinical Target audience : Clinician, Nurse Chairs : Alvar Agusti Garcia-Navarro (Barcelona, Spain), Claus Vogelmeier (Marburg, Germany) 13:00 13:30 Defintion and assessment of COPD Bartolome R. Celli (Boston, United States of America) Evaluation and treatment of comorbidities Leonardo Michele Fabbri (Modena, Italy) 4461 4462 14:00 Definition, treatment and prevention of exacerbations Wisia Wedzicha (London, United Kingdom) Room B Session 622 13:00 - 14:30 Lunchtime session: Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer? Pro/con discussions 4463 292 26.08.2016
ERS International Congress 2016 DETAILED PROGRAMME TUESDAY 06 SEPTEMBER, 2016 Aims : Today, immunooncology has almost completely revolutionised the treatment of various cancer types, especially lung cancer. Moreover, encouraging preliminary data are available for mesothelioma. These entities respond to PD-1 and PD-L1 inhibition. In addition, more and more targeted agents for lung cancer therapy are becoming available: these agents go beyond the tyrosine kinase blockade of mutated EGFR and rearranged ALK. Another marked advance is Next Generation Sequencing (NGS), which facilitates the detection of many dozens of mutations at the same time. However, the provocative question from the clinical standpoint remains: is detailed molecular testing essential for treating patients with these drugs? Track(s) : Oncology Tag(s) : Clinical Target audience : Clinician, Fellow, Immunologist, Junior member, Oncologist, Pathologist, Pharmaceutical industry representative, Public health official, Pulmonologist, Researcher, Resident, Respiratory physician, Scientist, Student, Thoracic surgeon Chairs : Joanna Chorostowska-Wynimko (Warszawa, Poland), Thomas Wehler (Homburg/Saar, Germany) 13:00 13:22 13:44 Is PD1/PD-L1 Resting ready for clinical practice? Pro Celine Mascaux (Marseille, France) Is PD1/PD-L1 Resting ready for clinical practice? Con Rainer G. Wiewrodt (Münster, Germany) Is Next Generation Sequencing Resting (NGSR) ready for clinical practice? Pro Joanna Chorostowska-Wynimko (Warszawa, Poland) 4464 4465 4466 14:06 Is Next Generation Sequencing Resting (NGSR) ready for clinical practice? Con Thomas Wehler (Homburg/Saar, Germany) Room K Session 623 13:00 - 14:30 ERS General Assembly and Council: ERS General Assembly Meeting Chairs : Jørgen Vestbo (Manchester, United Kingdom) Room ICC Capital Suite 7 Session 624 13:00 - 14:30 Educational forum: Recertification of respiratory professionals: current practice and the future Aims : To discuss the upcoming trends and challenges in recertification for respiratory professionals; to learn from best practices in different countries. Target audience : Pulmonologist, Educationalist, Clinician, Epidemiologist, General practitioner, Fellow, Junior member, Nurse, Oncologist, Paediatrician, Pathologist, Respiratory physician, Resident, Physiotherapist, Thoracic endoscopist, Thoracic surgeon, Sleep specialist/technologist, Respiratory therapist Chairs : Ildikó Horváth (Budapest, Hungary) 4467 13:00 13:20 Definition and importance Carolin Sehlbach (Maastricht, Netherlands) Recertification in practice across the world Frank W.J.M. Smeenk (Eindhoven, Netherlands), Luis Pérez de Llano (Lugo, Spain), Akihito Yokoyama (Kochi, Japan), Carey C. Thomson (Boston, United States of America), Jonathan Bennett (Leicester, United Kingdom) 4468 4469 14:00 Panel discussion Frank W.J.M. Smeenk (Eindhoven, Netherlands), Luis Pérez de Llano (Lugo, Spain), Akihito Yokoyama (Kochi, Japan), Carey C. Thomson (Boston, United States of America), Jonathan Bennett (Leicester, United Kingdom) Room ICC Capital Suite 8 Session 625 13:00 - 14:00 Patient forum: Communicating the impact and risk of air pollution to respiratory patients A joint ELF/ERS session Aims : To look at the ways in which healthcare professionals can best relay information to respiratory patients about the many issues surrounding air quality and lung health; to investigate the best way to communicate the dangers and the risks to make sure that patients are well informed and ready to take the most appropriate action. Tag(s) : Healthy Lungs for Life (HLfL) Chairs : Jonathan Grigg (London, United Kingdom), Dan Smyth (Dundalk, Ireland) 4470 13:00 Communicating the impact and risk of air pollution to respiratory patients (, ), Chris J. Griffiths (Cambridge, United Kingdom) 5506 293 26.08.2016
Page 1:
HELP SHAPE THE FUTURE OF RESPIRATOR
Page 4 and 5:
WELCOME FROM THE CONGRESS CHAIRS ER
Page 6 and 7:
ERS LONDON 2016 Data scanning syste
Page 8 and 9:
MAPS ERS LONDON 2016 ■ CONGRESS M
Page 10 and 11:
MAPS ERS LONDON 2016 ■ EXHIBITION
Page 12 and 13:
ERS MAPSWORLD VILLAGE ERS LONDON 20
Page 14 and 15:
INVITATION JOIN US AT THE OPENING C
Page 16 and 17:
CONGRESS RESOURCES AREA Te Congress
Page 18 and 19:
ERS-SPLF Joint Session Saturday 3 S
Page 20 and 21:
ERS-CTS Joint Session Saturday 3 Se
Page 22 and 23:
PROGRAMME AT A GLANCE
Page 24 and 25:
ERS International Congress 2016 OUT
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
WORLD VILLAGE SESSIONS
Page 44 and 45:
PROGRAMME DETAILS
Page 46 and 47:
ERS International Congress 2016 DET
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
ERS International Congress 2016 Roo
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
ERS International Congress 2016 T-0
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
ERS International Congress 2016 T-1
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
ERS International Congress 2016 Pla
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
ERS International Congress 2016 ICC
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287: ERS International Congress 2016 DET
Page 300 and 301: ERS International Congress 2016 T-1
Page 338 and 339: ERS International Congress 2016 13:
Page 354 and 355: ERS International Congress 2016 Pla
Page 378 and 379: ERS International Congress 2016 WOR
Page 384 and 385: ERS International Congress 2016 IND
Page 386 and 387:
ERS International Congress 2016 IND
Page 388 and 389:
INDUSTRY SPONSORED SESSIONS DISCLAI
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
CHAIR AND COORDINATOR INDEX Name, S
Page 410 and 411:
CHAIR AND COORDINATOR INDEX S., 456
Page 412 and 413:
SPEAKER INDEX 4753, 4758, 4759 GIBS
Page 414 and 415:
SPEAKER INDEX ZAR H., 1734 ZAVORSKY
Page 416 and 417:
AUTHOR INDEX AKHTER S., PA1020, 118
Page 418 and 419:
AUTHOR INDEX ARAUJO SILVA C., PA136
Page 420 and 421:
AUTHOR INDEX 4323, 4866, 4869 BARBA
Page 422 and 423:
AUTHOR INDEX BILTON D., PA2633, PA4
Page 424 and 425:
AUTHOR INDEX BROWN M., PA5047 BROWN
Page 426 and 427:
AUTHOR INDEX PA2759 CASTIGLIA D., P
Page 428 and 429:
AUTHOR INDEX ALVAREZ B., PA1034 CIM
Page 430 and 431:
AUTHOR INDEX D’ORAZIO C., OA1489,
Page 432 and 433:
AUTHOR INDEX DEVRAJ M., PA2689 DEWA
Page 434 and 435:
AUTHOR INDEX EL ANDALOUSSI M., PA25
Page 436 and 437:
AUTHOR INDEX PA2634, PA2636, 3266,
Page 438 and 439:
AUTHOR INDEX GARCIA MOYANO M., PA23
Page 440 and 441:
AUTHOR INDEX GORHAM J., PA2820 GORI
Page 442 and 443:
AUTHOR INDEX HANIBUCHI M., PA778 HA
Page 444 and 445:
AUTHOR INDEX HOLMES L., PA4101, PA4
Page 446 and 447:
AUTHOR INDEX JADDOE V., PA3134 JADH
Page 448 and 449:
AUTHOR INDEX KANG B., PA1160, 2485
Page 450 and 451:
AUTHOR INDEX KJELDGAARD P., PA1125,
Page 452 and 453:
AUTHOR INDEX KUNA P., OA256, PA964,
Page 454 and 455:
AUTHOR INDEX PA5096 LEPEJ D., PA129
Page 456 and 457:
AUTHOR INDEX PA1311 MACEDO C., PA25
Page 458 and 459:
AUTHOR INDEX MARTÍNEZ-MEMIJE R., P
Page 460 and 461:
AUTHOR INDEX MIKURA S., PA4847 MILA
Page 462 and 463:
AUTHOR INDEX MOYA A., PA3762 MOYA A
Page 464 and 465:
AUTHOR INDEX NIKOLETOU D., PA1368 N
Page 466 and 467:
AUTHOR INDEX PA1569 OUPADIA S., PA2
Page 468 and 469:
AUTHOR INDEX OA1802, PA2083, PA2373
Page 470 and 471:
AUTHOR INDEX PPATHANASSIOU E., PA41
Page 472 and 473:
AUTHOR INDEX PA4311, PA4325 RIBEIRO
Page 474 and 475:
AUTHOR INDEX SABOGAL PINEROS Y., PA
Page 476 and 477:
AUTHOR INDEX SCHMIDT A., PA902 SCHM
Page 478 and 479:
AUTHOR INDEX SIMIDCHIEV A., PA300 S
Page 480 and 481:
AUTHOR INDEX STANCHEVA G., PA2854,
Page 482 and 483:
AUTHOR INDEX PA4357, PA4359 TAN L.,
Page 484 and 485:
AUTHOR INDEX TRIEBNER K., 629, OA49
Page 486 and 487:
AUTHOR INDEX PA601, PA1825, 2903, 3
Page 488 and 489:
AUTHOR INDEX PA3864, 4501, 4856 WAL
Page 490 and 491:
AUTHOR INDEX YAMAMOTO A., PA569, PA
show all

CONGRESS GUIDE

Create successful ePaper yourself

Delete template?

Save as template?